Navigation Links
Imagenetix, Inc. Reports Year End Results
Date:6/17/2009

----- --- Operating expenses 4,377 4,456 Operating income (loss) (919) (2,230) Other income 25 32 Settlement income 1,785 - Interest expense (2) (4) --- --- Income (loss) before income taxes 889 (2,202) Income tax expense (benefit) 459 (425) --- ---- Net income (loss) $430 $(1,777) ---- ------- Income (loss) per share: Basic $0.04 $(0.16) Diluted $0.04 $(0.16) Weighted average common shares outstanding: Basic 10,991 10,937 Diluted 11,010 10,937 Imagenetix, Inc. Condensed Consolidated Balance Sheets (In thousands) March 31, March 31, 2009 2008 ---- ---- Assets: Current assets: Cash and cash equivalents $1,226 $1,023 Accounts receivable, net 1,096 766 Inventories, net 1,337 1,110 Prepaid expenses and other current assets 109 252 Deferred tax asset
'/>"/>
SOURCE Imagenetix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Imagenetix, Inc. Reports Third Quarter and Nine Month Results
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... EDINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmo...Butachiropractorcanalsogivepatientsthehelptheyneed...ereyourjaw(mandible)contacts/connectswithyourskull...tedwithTMJdysfunctionarepainwithchewing,clickingor...mTMJdysfunctionincluding:headaches,fatigue,sleepdi...
(Date:11/25/2009)... TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,...ualizationsoftwarelaunchesasuiteofnewleadingedgecl...wareplatformatthisyear,sRadiologicalSocietyofNorth...009(Booth5800,HallA).Theapplicationsleveragetheuni...izedMRIimagingcoilsandsupportmultipleimagingmodali...
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...ortuitous discovery that grew out of a collaborati...entially offer hope to the nearly 10 million Ameri... , Also known as hardening of the arteries, p...rculatory problem in which narrowed arteries reduc...ered a red flag for vascular disease, heart attack...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...wn to have a genetic predisposition. //This study ... DNA double helix. Collaborated Research is b...de Hospital campus of The Feinstein Institute for ... that vary dramatically in symptoms and severity a...
...greement to deliver a fast, efficient new electron...ve as a win for patients and doctors alike. T...irst organisation to sign up to deliver the new sy...mmittee on Information Technology, Dr Peter Garcia...
...and disappointment on hearing the news about a Lib...ences on five Bulgarian nurses and one Palestinian...reds of children with HIV. George Bush has exp...urses would be fully supported by him. The US ...
...IDF) Diabetes Atlas released early December in Sou...hest in India.// But China overtakes India in the ...T). The Atlas, third in a series that began i... is predicted to increase dramatically over the ne...
...read to many different sites often do not have man...to tolerate the doses of treatment they would need... Hope and St. Jude Children's Research Hospital ma...trate chemotherapeutic drugs predominately at tumo...
... research centre is being planned at the Pune-base...eat diseases//, a general says. "Stem cell ther...edicine. It will be the futuristic treatment repla...e disease and various other diseases can be cured,...
Other Medicine News:Health News:Research on Bipolar Disorder Launched 2Health News:Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer 2Health News:Military College to Set Up Stem Cell Research Centre 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...NEY,Nov.25/PRNewswire-FirstCall/--HeartWareInterna...orandprovideroflessinvasive,miniaturizedcirculator...dvancedheartfailure,todayannouncedthatitisschedule...affrayHealthCareConferenceat8:00amESTonWednesday,D...PalaceHotel,December1-2. ,, AlivewebcastoftheCo...
(Date:11/24/2009)...wswire/-- ,, WHAT:RomHoubens,aBelgianmanthought...wasactuallyfullyconsciousandawakeduringthattimeand...oxEyeMaxwasfeaturedinthesegmenttoillustratehowpeop...communication. ,, WHEN:GoodMorningAmerica-- Tue...ch.com ,, WHO:RomHoubenswasanengineeringstu...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 1InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 2InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 3InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 4InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 5InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 6InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 7InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 8InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 9InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 10InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 11InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 12InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 13InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 14InterMune Reports Second Quarter 2009 Financial Results and Business Highlights 13428 15OncoGenex Reports Second Quarter 2009 Financial Results 13426 1OncoGenex Reports Second Quarter 2009 Financial Results 13426 2OncoGenex Reports Second Quarter 2009 Financial Results 13426 3OncoGenex Reports Second Quarter 2009 Financial Results 13426 4OncoGenex Reports Second Quarter 2009 Financial Results 13426 5OncoGenex Reports Second Quarter 2009 Financial Results 13426 6OncoGenex Reports Second Quarter 2009 Financial Results 13426 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improved Progression Free Survival in First Line Metastatic Colorectal Cancer 4834 8
...Newswire/ -- Phase 3 results,from the RE-NOVATE(TM...e once daily, administered for an average of 33 da...red for an average of 33,days, in preventing venou...ter total hip replacement surgery. In this trial, ...ran etexilate was,similar to enoxaparin. The incid...
.../ -- A new study suggests,strong variation in the ... southern U.S. Anaphylaxis is a severe allergic,re...inephrine. The,striking north-south differences in... currently are without explanation. The,investigat...in D,from lack of sunshine, may play a role and th...
Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2
OCUFLOX® 5 mL
ALPHAGAN® 5 mL
ACULAR® 5 mL
ACULAR® 10 mL
Medicine Products: